Immune Changes in Severe COVID-19 Pulmonary Infections

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

March 30, 2020

Primary Completion Date

May 30, 2020

Study Completion Date

June 30, 2021

Conditions
SARS-CoV-2Immune System Disorder
Trial Locations (1)

54511

Centre Hospitalier Universitaire NANCY, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT04386395 - Immune Changes in Severe COVID-19 Pulmonary Infections | Biotech Hunter | Biotech Hunter